Jove
Visualize
Contact Us

Related Experiment Videos

Liver Metastases.

Kemeny1, Ron

  • 1Memorial Sloan-Kettering Cancer Center, Room H916, 1275 York Avenue, New York, NY 10021.

Current Treatment Options in Gastroenterology
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Resectable liver metastases, especially from colorectal cancer, are curable with surgery. For unresectable or advanced cases, systemic chemotherapy, regional therapies, or newer approaches like chemoembolization are considered.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Negatively charged quantum well polaritons in a GaAs/AlAs microcavity: An analog of atoms in a cavity

Physical review letters·2000
Same author

Whole-Body FDG-PET in Patients with Recurrent Colorectal Carcinoma. A Comparative Study with CT.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2000
Same author

Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery.

Advanced drug delivery reviews·2000
Same author

Editorial

Immunology·2000
Same author

RESPONSE: re: thyroid cancer rates and (131)I doses from nevada atmospheric nuclear bomb tests

Journal of the National Cancer Institute·1999
Same author

Charged and neutral exciton phase formation in the magnetically quantized two-dimensional electron gas.

Physical review. B, Condensed matter·1996
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Hepatology
  • Surgical Oncology

Background:

  • Liver metastases, particularly from colorectal cancer, represent a significant clinical challenge.
  • Advancements in imaging (CT, MRI, sonography) and surgical techniques have improved diagnosis and treatment options.
  • Non-anatomic dissections have expanded the resectability of multiple liver lesions.

Purpose of the Study:

  • To review current treatment strategies for liver metastases.
  • To discuss the role of surgery, systemic therapy, and regional interventions.
  • To explore newer modalities for managing liver metastases.

Main Methods:

  • Review of diagnostic imaging techniques (CT, MRI, sonography).
  • Analysis of surgical resection outcomes, including non-anatomic dissections.

Related Experiment Videos

  • Evaluation of systemic chemotherapy, hepatic arterial infusion, and regional therapies (embolization, chemoembolization).
  • Discussion of emerging techniques: cryosurgery, interstitial radiation.

    • Main Results:

    • Surgical resection of solitary or up to four colorectal metastases is considered the optimal treatment.
    • Expectant follow-up is recommended for elderly patients or those with comorbidities if the tumor is stable.
    • Systemic chemotherapy or hepatic arterial infusion is indicated for progressive disease.
    • For neuroendocrine tumors, initial observation is preferred, with Sandostatin for symptom management, followed by embolization/chemoembolization if progression occurs.
    • Newer ablative and regional techniques (cryosurgery, chemoembolization, radiation) offer alternatives when surgery is not feasible, though their efficacy compared to standard treatments is under investigation.

    Conclusions:

    • Surgical resection remains the gold standard for resectable liver metastases from colorectal cancer.
    • A multimodal approach involving surgery, systemic therapy, and regional interventions is crucial for managing diverse liver metastasis scenarios.
    • Ongoing research is vital to establish the definitive role of newer techniques in the treatment paradigm.